Sign in
Taking people in United StatesNo phase

Tablet brain health check in primary care for memory problems and dementia

Tests a tablet-based memory check to spot cognitive impairment in primary care patients.

Key facts

Who runs it
University of California, San Francisco
Where
Pasadena, United StatesSee the site
Trial code
Registry title
TabCAT Brain Health Assessment in Primary Care
Status
Recruiting
People taking part
180,000 people, planned
Started
27 Jul 2023
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • TabCAT Brain Health Assessment Clinical Pathway
Record updated
31 October 2025

Who can take part

The trial is looking for adult patients seen at 26 Kaiser Southern California primary care clinics. It tests a tablet-based brain health check to find memory and thinking problems, including dementia.

Age
18 years and older (the main analyses use people aged 65 and older)
Sex
All sexes
Main reasons for not taking part
  • People under the age of 18 cannot join.
  • You need at least one visit at a study clinic during the study period.
Show the full registry criteria (3)Hide the full registry criteria

Who can take part

  • Patient with at least one encounter at an intervention clinic during the intervention period
  • Age 18+ (limited to 65+ for primary analyses)

Who cannot take part

  • Patients under the age of 18

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Mild cognitive impairment or dementia

This trial is currently available in United States.

  • Kaiser Permanente Southern California Department of Research & EvaluationPasadena, United StatesContact: Huong Q Nguyen, PhDTaking people

About the trial

What the trial wants to find out

Efficient and user-friendly paradigms to detect cognitive impairment, including dementia are needed in primary care. The TabCAT Brain Health Assessment accurately detects cognitive impairment via an appealing tablet interface with automated scoring and EMR integration. This study will evaluate the effectiveness of the paradigm on detection rates and other brain health outcomes via a pragmatic cluster randomized trial in 26 Kaiser Southern California primary care clinics.

The 2 groups in the trial

  • TabCAT-Brain Health Assessment Clinical PathwayTreatment being tested

    Primary care providers concerned that their patients are exhibiting signs of cognitive decline based on patient, informant (family), or provider concerns will refer them for a TabCAT-BHA assessment and follow-up care.

  • Usual Care Clinical PathwayNo study treatment, for comparison

    Patients in the control practices will continue with usual care workflows.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Pragmatic Trial of the TabCAT Brain Health Assessment for the Detection of Cognitive Impairment in Primary Care
Plain-language title
Tablet brain health check in primary care for memory problems and dementiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06090578, who can take part
Record updated
31 October 2025